When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XERS - FDA extends action date 90 days for Xeris Pharma's glucagon rescue pen
Xeris Pharmaceuticals Inc.
The FDA has extended its action date to September 10 for its review of Xeris Pharmaceuticals' (NASDAQ:XERS) marking application for Gvoke (ready-to-use glucagon injection) for the treatment of severe hypoglycemia (low blood sugar).
More news on: Xeris Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,